Please Do Not Just Run Out of Refills
A 2026 study from Washington University found that patients who stopped GLP-1 medications saw their cardiovascular protection reverse — faster than most doctors expected. Even a six-month gap was associated with measurable increases in heart attack and stroke risk. After two years off therapy, the risk climbed by up to 22%.
The researchers found that inflammation markers rose, insulin resistance returned, blood pressure increased, and cholesterol crept back up. As one researcher put it: it takes a long time to build cardiovascular protection, but about half as much time to undo it.
What This Means for You
This is not meant to trap you on medication forever. It is meant to help you make informed decisions. If you are thinking about stopping — or if you have already stopped because of cost, side effects, or life circumstances — here is what to consider:
- If cost is the reason: Switch to a cheaper option before stopping entirely. Compounded semaglutide from $99/month or oral pills from $149/month are better than nothing.
- If side effects are the reason: Talk to your provider about dose reduction, medication switching, or trying the oral formulation.
- If you reached your goal weight: Discuss maintenance dosing. Staying on a lower dose may preserve both weight loss and cardiovascular protection.
- If you already stopped: It is not too late to restart. Talk to your provider about resuming treatment at an appropriate dose.
The most dangerous way to stop:
Running out of refills and not scheduling a replacement. Life gets busy. But if your provider does not know you have stopped, no one is monitoring the cardiovascular changes happening under the surface. Please tell your doctor before or immediately after stopping.
Need a More Affordable Way to Stay on Treatment?
Compare providers starting at $99/month. Continuity matters more than the brand.
Compare Providers →